Prevalence of herpes simplex virus type 2 antibody in Cameroon

Sexually Transmitted Diseases

Volumn 29, Issue 11, 2002, Pages 637-642

  Eis Hübinger, Anna Maria ^a   Nyankiye, Emmanuel ^b   Bitoungui, Didier Mboua ^c   Ndjomou, Jean ^a,d  

^a UNIVERSITY OF BONN   (Germany)

^b Chest Clinic   (Cameroon)

^c Sexually Transmitted Disease Clinic   (Cameroon)

^d University Hospitals   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CAMEROON; ENZYME IMMUNOASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE;

EID: 0036843066     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200211000-00004     Document Type: Article

References (43)

1. Corey L, Handsfield HH. Genital herpes and public health: Addressing a global problem. JAMA 2000; 283:791-794.
2. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet 2001; 357:1513-1518.
3. Langenberg AGM, Corey L, Ashley RL, Leong WP, Straus SE, for the Chiron HSV Vaccine Study Group. A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 1999; 341:1432-1438.
4. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: Impact on surveillance and prevention. J Infect Dis 2000; 181:1454-1457.
5. Nahmias AJ, Dowdle WR, Naib ZM, Josey WE, McLone D, Domescik G. Genital infection with type 2 herpes virus hominis: A commonly occurring venereal disease. Br J Vener Dis 1969; 45:294-298.
6. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: Clinical manifestations, course, and complications. Ann Intern Med 1983; 98:958-972.
7. Whitley RJ. Neonatal herpes simplex virus infections. J Med Virol 1993; Suppl 1:13-21.
8. Kohl S. Herpes simplex infections in newborn infants. Semin Ped Infect Dis 1999; 10:154-160.
9. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280:61-66.
10. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197-202.
11. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844-850.
12. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: Effect of acyclovir treatment. J Clin Invest 1997; 99:1092-1097.
13. Bernstein DI, Bryson YJ, Lovett MA. Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides. J Med Virol 1985; 15:251-263.
14. Ashley R, Benedetti J, Corey L. Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes. J Med Virol 1985; 17:153-166.
15. Ashley RL, Militoni J. Use of densitometric analysis for interpreting HSV serologies based on Western blot. J Virol Methods 1987; 18:159-168.
16. Ho DWT, Field PR, Irving WL, Packham DR, Cunningham AL. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol 1993; 31:3157-3164.
17. Ashley RL, Wald A. Genital herpes: Review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999; 12:1-8.
18. Lee FK, Coleman RM, Pereira L, Bailey PD, Tatsuno M, Nahmias AJ. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 1985; 22:641-644.
19. Liljeqvist JA, Svennerholm B, Bergström T. Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates. J Clin Microbiol 2000; 38:4517-4522.
20. Whittington WL, Celum CL, Cent A, Ashley RL. Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics. Sex Transm Dis 2001; 28:99-104.
21. Enders G, Risse B, Zauke M, Bolley I, Knotek F. Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific enzyme immunoassay. Eur J Clin Microbiol Infect Dis 1998; 17:870-872.
22. Eis-Hübinger AM, Däumer M, Matz B, Schneweis KE. Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera. J Clin Microbiol 1999; 37:1242-1246.
23. Groen J, Hersmus B, Niesters HGM, et al. Evaluation of a fully automated glycoprotein G-2 based assay for the detection of HSV-2 specific IgG antibodies in serum and plasma. J Clin Virol 1999; 12:193-200.
24. Johnson RE, Nahmias AJ, Magder LS, et al. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989; 321:7-12.
25. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994; 309:1325-1329.
26. Wagner HU, Van Dyck E, Roggen E, et al. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS 1994; 5:332-337.
27. Rosenthal SL, Stanberry LR, Biro FM, et al. Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin Infect Dis 1997; 24:135-139.
28. Kamali A, Nunn AJ, Mulder DW, Van Dyck E, Dobbins JG, Whitworth JAG. Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Infect 1999; 75:98-102.
29. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis 1999; 179:16-24.
30. Langeland N, Haarr L, Mhalu F. Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania. Int J STD AIDS 1998; 9:104-107.
31. Mostad SB, Kreiss JK, Ryncarz AJ, et al. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: Effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis 2000; 181:58-63.
32. Mbopi-Kéou FX, Grésenguet G, Mayaud P. et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: Opportunities for intervention. J Infect Dis 2000; 182:1090-1096.
33. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990; Suppl 69:19-36.
34. Cunningham AL, Lee FK, Ho DW, et al. Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med J Austr 1993; 158:525-528.
35. Arvaja M, Lehtinen M, Koskela P, Lappalainen M, Paavonen J, Vesikari T. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect 1999; 75:168-171.
36. Wutzler P, Doerr HW, Färber I, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations: Relevance for the incidence of genital herpes. J Med Virol 2000; 61:201-207.
37. Cusini M, Cusan M, Parolin C, et al. Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Sex Transm Dis 2000; 27:292-295.
38. Varela JA, Gárcia-Corbeira P, Agüanell MV, et al. Herpes simplex virus type 2 seroepidemiology in Spain: Prevalence and seroconversion rate among sexually transmitted disease clinic attendees. Sex Transm Dis 2001; 28:47-50.
39. Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis 2001; 28:424-428.
40. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1111.
41. Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: Occurrence and determinants of infection. J Infect Dis 1990; 162:306-12.
42. Breinig MK, Kingsley LA, Armstrong JA, Freeman DJ, Ho M. Epidemiology of genital herpes in Pittsburgh: Serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 1990; 162:299-305.
43. Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Commun Health 1989; 43:53-60.